METTL3 and osteoporosis: Silencing METTL3 suppressed the osteogenic differentiation of BMSCs, leading to impaired bone formation and bone marrow fat accumulation, and METTL3 overexpression alleviated estrogen deficiency-caused osteoporosis [14].